Harte-Hanks revamps digital practice

Share this article:
Harte-Hanks' Glen Hartman
Harte-Hanks' Glen Hartman

Harte-Hanks has announced a series of changes and promotions as it enhances its digital practice area.

Glen Hartman has been promoted to managing director of the digital practice.

Previously, Hartman led Harte-Hanks as an SVP for digital marketing for data-based marketing solutions. In his new role, Hartman is responsible for managing all aspects of the digital practice and its offerings including web site development, online advertising, search engine marketing, e-mail, mobile messaging, Web analytics and social networking.

In addition, the digital practice has added to its management team with several new hires. These hires include Julie Donovan, VP/practice leader, digital media; Thomas Molitor, VP/practice leader, digital interaction; Gary Druckenmiller Jr., VP, strategy & business development, digital practice.

“The Harte-Hanks digital practice has grown considerably throughout the past year,” Frank Harvey, corporate officer and VP said in a statement. “While this growth represents the increasing importance of digital media and marketing, it also represents the value of our digital expertise including the understanding we provide to our clients about how digital applications and their successful executions feed a larger multichannel strategy.”

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.